Literature DB >> 2743504

Ganoderic acid and its derivatives as cholesterol synthesis inhibitors.

Y Komoda, M Shimizu, Y Sonoda, Y Sato.   

Abstract

Oxygenated lanosterol derivatives, which were isolated from Ganoderma lucidum (Polyporaceae) or their derivatives obtained by chemical conversion, were tested for their effect on cholesterol biosynthesis from 24,25-dihydrolanosterol by rat hepatic subcellular 10,000 x g supernatant fraction. The sterol (VI, 40 microM) with 7-oxo and 15 alpha-hydroxy groups potently inhibited the synthesis of cholesterol from [24,25-3H]-24,25-dihydrolanosterol (18 microM).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2743504     DOI: 10.1248/cpb.37.531

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  14 in total

Review 1.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

2.  Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors.

Authors:  Hassan Hajjaj; Catherine Macé; Matthew Roberts; Peter Niederberger; Laurent B Fay
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

Review 3.  Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling.

Authors:  Balraj Singh Gill; Prateek Sharma; Raj Kumar; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2015-12-30

4.  Ganoderma lucidum inhibits inducible nitric oxide synthase expression in macrophages.

Authors:  Connie W H Woo; Ricky Y K Man; Yaw L Siow; Patrick C Choy; Eric W Y Wan; Chak S Lau; Karmin O
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

5.  Apoptotic and Immune Restoration Effects of Ganoderic Acids Define a New Prospective for Complementary Treatment of Cancer.

Authors:  Faisal F Y Radwan; J Manuel Perez; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2011-12-11

6.  Induction of apoptosis in the SW620 colon carcinoma cell line by triterpene-enriched extracts from Ganoderma lucidum through activation of caspase-3.

Authors:  Zhe Ji; Qingjiu Tang; Ruixia Hao; Jinsong Zhang; Yingjie Pan
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

Review 7.  Mushrooms: an emerging resource for therapeutic terpenoids.

Authors:  Adhiraj Dasgupta; Krishnendu Acharya
Journal:  3 Biotech       Date:  2019-09-24       Impact factor: 2.406

Review 8.  Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors.

Authors:  Nerida L Klupp; Dennis Chang; Fiona Hawke; Hosen Kiat; Huijuan Cao; Suzanne J Grant; Alan Bensoussan
Journal:  Cochrane Database Syst Rev       Date:  2015-02-17

9.  Medicinal mushrooms: Towards a new horizon.

Authors:  A Ganeshpurkar; G Rai; A P Jain
Journal:  Pharmacogn Rev       Date:  2010-07

10.  Target proteins of ganoderic acid DM provides clues to various pharmacological mechanisms.

Authors:  Jie Liu; Kuniyoshi Shimizu; Akinobu Tanaka; Wakako Shinobu; Koichiro Ohnuki; Takanori Nakamura; Ryuichiro Kondo
Journal:  Sci Rep       Date:  2012-11-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.